S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
Salesforce.com Is More Attractive After 10% Discount
Zscaler, Inc Is Going Ballistic, It’s Not Too Late To Hitch A Ride
Exxon Mobil ups spending on emission reduction plan to $15B
Omicron keeps world jittery as more information drips out
Selloff Makes These 3 Retail Stocks Worth Buying
Zoom Video (NASDAQ: ZM) Catches A Much Needed Break
GM venture to build North American battery chemical plant
S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
Salesforce.com Is More Attractive After 10% Discount
Zscaler, Inc Is Going Ballistic, It’s Not Too Late To Hitch A Ride
Exxon Mobil ups spending on emission reduction plan to $15B
Omicron keeps world jittery as more information drips out
Selloff Makes These 3 Retail Stocks Worth Buying
Zoom Video (NASDAQ: ZM) Catches A Much Needed Break
GM venture to build North American battery chemical plant
S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
Salesforce.com Is More Attractive After 10% Discount
Zscaler, Inc Is Going Ballistic, It’s Not Too Late To Hitch A Ride
Exxon Mobil ups spending on emission reduction plan to $15B
Omicron keeps world jittery as more information drips out
Selloff Makes These 3 Retail Stocks Worth Buying
Zoom Video (NASDAQ: ZM) Catches A Much Needed Break
GM venture to build North American battery chemical plant
S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
Salesforce.com Is More Attractive After 10% Discount
Zscaler, Inc Is Going Ballistic, It’s Not Too Late To Hitch A Ride
Exxon Mobil ups spending on emission reduction plan to $15B
Omicron keeps world jittery as more information drips out
Selloff Makes These 3 Retail Stocks Worth Buying
Zoom Video (NASDAQ: ZM) Catches A Much Needed Break
GM venture to build North American battery chemical plant
NASDAQ:APEN

Apollo Endosurgery Insider Trades

$8.10
+0.14 (+1.76%)
(As of 12/1/2021 12:00 AM ET)
Add
Compare
Today's Range
$8.02
▼
$8.37
50-Day Range
$7.96
▼
$10.11
52-Week Range
$3.23
▼
$10.39
Volume
195,816 shs
Average Volume
366,834 shs
Market Capitalization
$232.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.13

Apollo Endosurgery (NASDAQ:APEN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
26.20%

Number Of
Insiders Buying
(Last 12 Months)
4

Amount Of
Insider Buying
(Last 12 Months)
$5.85 M

Number Of
Insiders Selling
(Last 12 Months)
2

Amount Of
Insider Selling
(Last 12 Months)
$466.13 K

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get APEN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Apollo Endosurgery stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Apollo Endosurgery (NASDAQ APEN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/15/2021Cpmg IncMajor ShareholderBuy683,871$7.75$5,300,000.25  
8/20/2021Chas MckhannCEOSell21,148$7.74$163,685.52  
8/18/2021Chas MckhannCEOSell21,156$8.21$173,690.76686,122  
8/11/2021Jeffrey G BlackCFOBuy25,000$8.75$218,750.0025,000  
5/19/2021David PacittiDirectorSell18,742$6.87$128,757.5418,142  
4/5/2021Neil GagnonMajor ShareholderBuy303$5.48$1,660.44402,580  
3/10/2021John R BarrDirectorBuy10,000$5.89$58,900.0016,070  
2/5/2021Neil GagnonMajor ShareholderBuy30,954$4.71$145,793.34382,470  
2/3/2021Neil GagnonMajor ShareholderBuy28,388$4.46$126,610.48351,516  
7/17/2020R Kent Mcgaughy JrDirectorBuy1,780,000$1.25$2,225,000.00  
5/10/2019Todd NewtonCEOBuy25,000$3.53$88,250.00317,668  
12/27/2018Stonepine Capital, L.P.Major ShareholderSell250,000$3.00$750,000.002,185,426  
12/26/2018Stonepine Capital, L.P.Major ShareholderSell500,000$3.00$1,500,000.002,435,426  
11/21/2018Stonepine Capital, L.P.Major ShareholderBuy57,430$3.41$195,836.302,932,196  
11/19/2018Stonepine Capital, L.P.Major ShareholderBuy54,200$3.40$184,280.002,932,196  
11/2/2018Stonepine Capital, L.P.Major ShareholderBuy300,000$5.00$1,500,000.002,877,996  
6/20/2018Matthew S CrawfordDirectorBuy363,500$5.50$1,999,250.00  
6/20/2018Stefanie L. CavanaughCFOBuy4,545$5.50$24,997.50  
6/20/2018Todd NewtonCEOBuy72,727$5.50$399,998.50268,606  
3/9/2018Matthew S CrawfordDirectorBuy4,038$6.20$25,035.6053,715  
1/3/2018Stonepine Capital, L.P.Major ShareholderBuy22,845$5.71$130,444.952,560,314  
12/29/2017Stonepine Capital, L.P.Major ShareholderBuy5,163$5.56$28,706.282,560,314  
12/26/2017Stonepine Capital, L.P.Major ShareholderBuy5,287$5.00$26,435.002,555,151  
12/22/2017Stonepine Capital, L.P.Major ShareholderBuy185,157$4.85$898,011.452,410,141  
12/20/2017Stonepine Capital, L.P.Major ShareholderBuy45,434$4.50$204,453.002,410,141  
11/7/2017Bret SchwartzhoffVPBuy9,500$4.24$40,280.0015,631  
7/26/2017Holdings A/S NovoMajor ShareholderSell50,130$6.90$345,897.001,334,772  
7/25/2017Richard J MeeliaDirectorBuy45,454$5.50$249,997.005,098  
7/25/2017Sciences L P Ptv IIMajor ShareholderBuy1,090,909$5.50$5,999,999.50  
7/25/2017Stefanie L CavanaughCFOBuy4,545$5.50$24,997.509,166  
7/25/2017Todd NewtonCEOBuy136,363$5.50$749,996.50167,129  
5/18/2017Todd NewtonCEOBuy2,121$6.22$13,192.6229,544  
5/17/2017William D Jr. McclellanDirectorBuy2,000$6.33$12,660.00  
5/11/2017A/S NovoMajor ShareholderSell105,000$5.63$591,150.001,455,472  
12/12/2014Daniel H PetreeDirectorBuy10,000$2.79$27,900.00  
8/20/2014Gary J G AtkinsonCFOBuy5,000$3.10$15,500.00  
8/19/2014Scott R PancoastCEOBuy10,000$3.00$30,000.00  
8/18/2014Scott R PancoastCEOBuy10,000$3.22$32,200.00  
12/19/2012Charles MathewsDirectorBuy5,000$4.98$24,900.00  
12/18/2012Scott R PancoastCEOBuy5,000$4.95$24,750.00  
(Data available from 1/1/2013 forward)












Apollo Endosurgery (NASDAQ:APEN) Insider Trade Frequently Asked Questions

Who is on Apollo Endosurgery's Insider Roster?

The list of insiders at Apollo Endosurgery includes Chas Mckhann, Cpmg Inc, David Pacitti, Jeffrey G Black, John R Barr, Neil Gagnon, R Kent Mcgaughy Jr, Stonepine Capital, L.P., and Todd Newton.Learn more on APEN's insiders

What percentage of Apollo Endosurgery stock is owned by insiders?

26.20% of Apollo Endosurgery stock is owned by insiders. Learn more on APEN's insider holdings

Which Apollo Endosurgery insiders have been buying company stock?

The following insiders have purchased Apollo Endosurgery stock in the last 24 months: Cpmg Inc ($5,300,000.25), Jeffrey G Black ($218,750.00), John R Barr ($58,900.00), Neil Gagnon ($274,064.26), and R Kent Mcgaughy Jr ($2,225,000.00).

How much insider buying is happening at Apollo Endosurgery?

Insiders have purchased a total of 2,558,516 Apollo Endosurgery shares in the last 24 months for a total of $8,076,714.51 bought.

Which Apollo Endosurgery insiders have been selling company stock?

The following insiders have sold Apollo Endosurgery stock in the last 24 months: Chas Mckhann ($337,376.28), and David Pacitti ($128,757.54).

How much insider selling is happening at Apollo Endosurgery?

Insiders have sold a total of 61,046 Apollo Endosurgery shares in the last 24 months for a total of $466,133.82 sold.

This page was last updated on 12/2/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.